BPG致力于知识发现和传播
预出版
2026/8/6 3:52:39 | Browse: 7 | 下载: 0
Publication Name 世界华人消化杂志
手稿编号 40647
手稿来源省、自治区或特别行政区 上海市
专业类型 消化肿瘤学
手稿栏目类型 文献综述
文章标题 ADC药物在胰腺癌治疗中的应用现状及进展
手稿来源 约稿
所有作者列表 管健, 宋彬
基金项目及其编号
通讯作者 宋彬, 博士, 副教授, 200082, 上海市杨浦区长海路168号, 海军军医大学第一附属医院肝胆胰脾外科. smmusb@126.com
关键词 ADC药物; 胰腺癌; 靶向治疗; 临床试验; 耐药机制
核心内容提要 胰腺癌预后差, 传统化疗疗效有限. 抗体偶联药物(antibody-drug conjugates, ADC)为其治疗新方向. 本文梳理ADC作用机制, 总结主流及新兴靶点研究进展, 分析疗效受限关键障碍, 指出ADC联合用药具备协同优势及转化前景, 为胰腺导管腺癌个体化治疗提供依据.
引文著录 管健, 宋彬. ADC药物在胰腺癌治疗中的应用现状及进展. 世界华人消化杂志 2026
Received
2026-06-12 07:16
Peer-Review Started
2026-06-12 09:03
To Make the First Decision
Return for Revision
2026-07-03 10:25
修回稿
2026-07-20 02:35
Second Decision
2026-07-30 08:36
期刊总编辑接受
公司总编辑接受
2026-08-06 03:52
预出版
2026-08-06 03:52
缴纳版面费
Edit the Manuscript by Language Editor
排版
ISSN 1009-3079 (print) and 2219-2859 (online)
开放获取 This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
版权 ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
网址 http://www.wjgnet.com
Assistant Editor 宣佳琪
Science Editor 刘继红
评议人编号 03210359, and 02687374
Editorial Director
Journal Chief Editor
Company Chief Editor 樊佳茹
Language Editor
Production Editor
Responsible Production Editor
Responsible Science Editor
Proofing Editorial Director Jin-Lei Wang
Proofing Editor-in-Chief Lian-Sheng Ma